Direct-to-consumer virtual care company Hims & Hers is partnering with Novo Nordisk to allow Americans to access a bundled offering that includes the pharma giant's obesity drug Wegovy and a Hims & Hers membership starting at $599 per month.
Hims & Hers members will have direct access to NovoCare Pharmacy, an offering through Novo Nordisk that allows cash-paying individuals without...
Microsoft’s AI for Good Lab has created Seq2Symm, an open-source AI tool that helps scientists determine the 3D shapes of certain proteins, including those found in viruses.
Seq2Symm uses AI to predict a protein's 3D shape and structure from a one-dimensional sequence. The tool could help researchers better understand diseases, develop drugs and vaccines, and create more sustainable materials....
Indianapolis-based pharmaceutical behemoth Eli Lilly has filed lawsuits against four compounders claiming that they sold unapproved products that contain tirzepatide, a key ingredient in the company's weight-loss and diabetes drugs, including top-seller Mounjaro.
The lawsuits against Mochi Health, Fella Health and Delilah, and Henry Meds were filed in the U.S. District Court Northern District of...
Genome British Columbia (Genome BC), a not-for-profit genomics research company, has secured $49 million in funding for five projects that will be conducted in British Columbia and will utilize genomics to advance personalized healthcare.
According to Genome BC, the projects are part of research funding announced in March by Genome Canada under the Canadian Precision Health Initiative (CPHI). ...
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates genomic therapies for neurodegenerative diseases.
Unlearn, founded in 2017, uses machine learning to create digital twins of clinical trial participants before being randomized in a controlled trial.
The...
A federal judge in Texas ruled that the FDA overstepped its authority when it issued its Final Rule: Medical Devices; Laboratory Developed Tests in May of last year, which said laboratory-developed tests (LDTs) should be regulated as medical devices.
In a 450-page lawsuit filed by the American Clinical Laboratory Association (ACLA), molecular testing laboratory for infectious diseases...
Tech-enabled drug discovery company Insilico Medicine secured $110 million in an oversubscribed Series E funding round.
A large equity fund of Value Partners Group, an asset management firm in Asia, and new and existing investors participated in the round.
WHAT IT DOES
Massachusetts-based Insilico's proprietary generative AI platform, Pharma.AI, utilizes biology, clinical medicine, scientific...
LAS VEGAS - At the 2025 HIMSS Global Conference & Exhibition here, Tom Leary, senior vice president and head of government relations at HIMSS, and Jonathan French, senior director of public policy and content development at HIMSS, discussed the organization's role in progressing health technology policy in government.
In their talk, "Forecasting the Global Policy Landscape in 2025," the pair...
LAS VEGAS - At the 2025 HIMSS Global Conference & Exhibition here, Herko Coomans, international digital health coordinator at the Ministry of Health, Welfare and Sport, highlighted the work of the Global Digital Health Partnership (GDHP) worldwide and the aim of the organization.
During his talk, "Digital Health Policy Collaboration on a Global Scale with the GDHP," Coomans said, "Every...
The University of Colorado Cancer Center (CU Cancer Center) and Flatiron Health are teaming up to make clinical trials more efficient by reducing administrative burdens on researchers.
The partnership brings Flatiron Clinical Pipe to CU Cancer Center and UCHealth, allowing clinical trial data to move directly from electronic health records (EHRs) to electronic data capture (EDC) systems.
The...
11c7.jpg "Seq2Symm proteins")
